XML 19 R8.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Selected Balance Sheet Data | 9 Months Ended
--- | ---
Mar. 31, 2024
Notes to Financial Statements |
Selected Balance Sheet Data | Note 3. Selected Balance Sheet Data: Inventories: Inventories consist of (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | March 31, | ​ | June 30,
​ |  | 2024 |  | 2023
​ | ​ | ​ | ​ | ​ | ​ | ​
Raw materials | ​ | $ | 80,524 | ​ | $ | 84,551
Finished goods(1) | ​ |  | 104,376 | ​ |  | 92,474
Inventories, net | ​ | $ | 184,900 | ​ | $ | 177,025
(1) Finished goods inventory of $5,404 and $5,387 included within Other long-term assets in the respective March 31, 2024 and June 30, 2023, Consolidated Balance Sheet. The inventory is included in long-term assets as it is forecasted to be sold after the 12 months subsequent to the consolidated balance sheet date. Property and Equipment: Property and equipment consist of (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | March 31, | ​ | June 30,
​ |  | 2024 |  | 2023
Land | ​ | $ | 8,159 | ​ | $ | 9,100
Buildings and improvements | ​ |  | 243,567 | ​ |  | 245,302
Machinery and equipment | ​ | ​ | 209,252 | ​ | ​ | 190,019
Construction in progress | ​ |  | 34,649 | ​ |  | 15,491
Property and equipment, cost | ​ |  | 495,627 | ​ |  | 459,912
Accumulated depreciation and amortization | ​ |  | (251,899) | ​ |  | (233,712)
Property and equipment, net | ​ | $ | 243,728 | ​ | $ | 226,200
​ Intangible Assets: Intangible assets consist of (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, | ​ | June 30,
​ | ​ | 2024 | ​ | 2023
​ | ​ | ​ | ​ | ​ | ​ | ​
Developed technology | ​ | $ | 652,788 | ​ | $ | 616,311
Trade names | ​ |  | 151,631 | ​ |  | 146,945
Customer relationships | ​ |  | 211,354 | ​ |  | 213,878
Patents | ​ |  | 4,149 | ​ |  | 3,815
Other intangibles | ​ |  | 11,872 | ​ |  | 11,566
Definite-lived intangible assets | ​ |  | 1,031,794 | ​ |  | 992,515
Accumulated amortization | ​ |  | (528,066) | ​ |  | (480,570)
Definite-lived intangibles assets, net | ​ |  | 503,728 | ​ |  | 511,945
In process research and development | ​ |  | 22,700 | ​ |  | 22,700
Total intangible assets, net | ​ | $ | 526,428 | ​ | $ | 534,645
​ Changes to the carrying amount of net intangible assets for the period ended March 31, 2024 consist of (in thousands):
​ | ​ | ​ | ​
​ | ​ | ​ | ​
Beginning balance | ​ | $ | 534,645
Acquisitions | ​ |  | 66,400
Other additions | ​ |  | 619
Held-for-sale intangibles(1) | ​ | ​ | (14,323)
Amortization expense | ​ |  | (60,056)
Currency translation | ​ | ​ | (857)
Ending balance | ​ | $ | 526,428
(1) Refer to Note 1 for further detail on held-for-sale intangibles. ​ The estimated future amortization expense for intangible assets as of March 31, 2024 is as follows (in thousands): ​
​ | ​ | ​ | ​
Remainder 2024 |  | $ | 19,525
2025 | ​ |  | 75,156
2026 | ​ |  | 71,191
2027 | ​ |  | 61,027
2028 | ​ |  | 57,380
Thereafter | ​ |  | 219,449
Total | ​ | $ | 503,728
​ ​ Goodwill: ​ Changes to the carrying amount of goodwill for the period ended March 31, 2024 consist of (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Diagnostics and |  | ​
​ | ​ | Protein Sciences | ​ | Genomics | ​ | Total
June 30, 2023 | ​ | $ | 427,027 | ​ | $ | 445,710 | ​ | $ | 872,737
Acquisitions | ​ |  | — | ​ | ​ | 102,546 | ​ | ​ | 102,546
Held-for-sale goodwill(1) | ​ | ​ | (1,400) | ​ | ​ | — | ​ | ​ | (1,400)
Currency translation | ​ |  | (1,526) | ​ | ​ | (1,391) | ​ | ​ | (2,917)
March 31, 2024 | ​ | $ | 424,101 | ​ | $ | 546,865 | ​ | $ | 970,966
(1)Refer to Note 1 for further detail on goodwill reclassified to current assets held-for-sale. ​ We evaluate the carrying value of goodwill in the fourth quarter of each fiscal year and between annual evaluations if events occur or circumstances change that would indicate a possible impairment. The Company performed a qualitative goodwill impairment assessment for all of its reporting units during the fourth quarter of fiscal 2023. No indicators of impairment were identified as part of our assessment. ​ Other Assets: ​ Other assets consist of (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | March 31, | ​ | June 30,
​ |  | 2024 | ​ | 2023
​ | ​ | ​ | ​ | ​ | ​ | ​
Equity method investment in Wilson Wolf | ​ | $ | 247,984 | ​ | $ | 255,857
Derivative instruments | ​ | ​ | 12,028 | ​ | ​ | 16,857
Long-term inventory | ​ | ​ | 5,404 | ​ | ​ | 5,387
Other | ​ |  | 6,724 | ​ |  | 7,201
Other assets | ​ | $ | 272,140 | ​ | $ | 285,302
​

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration